The trial will be conducted across 10 sites in India. Zydus Cadila's ZyCoV-D is so far the only vaccine to get Emergency Use Authorisation in the 12-18 years age group in India.
DCGI modifies earlier order on emergency approval of well-established vaccines, waives several requirements, but retains assessment of first 100 beneficiaries before proper roll out.
The drug has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of DRDO, in collaboration with Dr Reddy's Laboratories in Hyderabad.
The DCGI will issue permission for restricted emergency use on the condition that the vaccine be used according to guidelines under the National Covid-19 Vaccination Programme.
In a letter to the Serum Institute, Drugs Controller General of India Somani said the institute is permitted to apply the shelf life of 9 months to unlabeled vials available on hand.
Child rights body issues summons over lack of standard testing methods to screen for presence of formaldehyde and asbestos in Johnson & Johnson’s baby shampoo and talcum powder.
Officials have 'indicated orally' that first 100mn vaccines will be purchased at Rs 200 & a deal should be inked 'in next one or two days', according to Serum CEO Adar Poonawalla.
A LocalCircles poll found that 70% of respondents felt their monthly household budget increased by 10% while 55% expected expenses to go up by another 10% in the next 3 months.
In February 2019, 72,400 SiG 716 rifles of 7.62 x 51mm calibre were contracted from SIG Sauer Inc, USA, under government's 'Buy (Global) category', through fast track procedure.
Like the car, nothing the party has done to reinvent itself has worked. Only way forward is to offer something looking towards the future, not in image of glorious past.